S100P and neoplasm: S100P has frequently been identified as an upregulated gene in PDAC48,53–59 and both the gene and the S100P protein are plausible therapeutic targets in PDAC, with cancer cell apoptosis and anti-tumor activity being consequences of targeting57,58.